Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06616155 |
| Title | Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer |
| Recruitment | Recruiting |
| Gender | male |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | University of Michigan Rogel Cancer Center |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Rush University | NOT_YET_RECRUITING | Chicago | Illinois | 60612 | United States | Details |
| University of Michigan Comprehensive Cancer Center | RECRUITING | Ann Arbor | Michigan | 48109 | United States | Details |
| Karmanos Cancer Institute | NOT_YET_RECRUITING | Detroit | Michigan | 48201 | United States | Details |